We Power Global Entrepreneurs

Boston attracts the best and brightest from everywhere, many of whom like you hope to launch the next big company. We deliver the support you need when you need it, to turn your vision into reality, beginning with a startup visa.

Join a thriving community thinking big from day-one

Say goodbye to the call-bell. RistCall’s platform connects patients and nurses wherever they are in the hospital. Founders Srinath Vaddepally and Ameya Bhat, from India, graduated from Carnegie Mellon University.

Ori’s robotic furniture makes a tiny apartment two times that size. Spinoff of the MIT Media Lab. Co-founders Ivan Fernandez de Casadevante and Hasier Larrea are from Spain.

No longer do volunteers have to roll up their sleeves to save a life. Platelet is a spinoff of Brigham and Woman’s Hospital. Founder Jonathan Thon is from Canada.

A spinoff of the Langer Lab at MIT, SQZ has demonstrated the ability to overcome many of the long standing challenges in the field of intracellular delivery. Founder Armon Sharei is from California.

Execute smartly with experience by your side

You’ll have unprecedented access to those who have already succeeded in executing a big vision. Our entrepreneurs-in-residence have worked with over 1,000 startups from the ground up. 

Be productive in a facility that cost-effectively satisfies every practical need and instinctive desire




Our facility is designed to help you obtain the data required to secure further investment and launch your company. Every imaginable type of instrument and workspace is at your disposal.

Need a visa to start your journey?

With a cap-exempt H-1B sponsored by UMass, you can stay in the country after you graduate and launch your business.

By the numbers





Companies Still Active

Latest news 

Boston biotech startup SQZ seals a $500M deal with drug giant Roche

Boston-based SQZ Biotech hasn’t even moved out of its incubator space at the Venture Development Center at the University of Massachusetts. Yet the deal with Roche is one that would be transformative for most of the areas’ larger, publicly-traded biotech firms.

CloudHealth Scoops Up $20M, Eyes IPO

The latest investment was led by new backer Sapphire Ventures, with contributions from previous CloudHealth investors Scale Venture Partners, .406 Ventures, and Sigma Prime Ventures. Now, the plan is to keep the foot on the gas. CloudHealth intends to grow its staff to over 150 people by the end of the year.

Platelet BioGenesis awarded $1.5 million SBIR grant

Platelet BioGenesis announced that it has received a Small Business Innovation Research (SBIR) grant valued at $1.5 million from the National Heart, Lung, and Blood Institute. By transitioning to a donor-independent system, patients will have access to safer platelets and will no longer be dependent on volunteer donors.

Gene-editing record smashed in pigs by eGenesis

For decades, scientists and doctors have dreamed of creating a steady supply of human organs for transplantation by growing them in pigs. Now, by modifying more than 60 genes in pig embryos — ten times more than have been edited in any other animal — researchers at eGenesis believe they may have produced a suitable non-human organ donor.

Want to join our community?